It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Kandinsky
reply to post by OccamsRazor04
Sorry, you can't tell someone they made enough money so now you are going to steal their product. It's theft. It's either theirs or it isn't. If it is, this is theft. If it isn't, then every country should just steal their products. Or is it just ok for India to do this, and no one else can? Why do some countries get to steal and some don't?
Your first points are accurate; you can't tell someone they've made enough profit or that it isn't their product any more.
However, there's a wider ethical question that isn't limited to simple property rights. I remember the Heinz Dilemma (ethics of stealing medicine) from university. It describes levels of moral development using the idea of a man seeking medicine to keep his wife alive. He can't afford the medicine and eventually steals it.
Morally, the Indians feels justified in producing medicines that save members of their population. Morally, they'd feel it was wrong to accept suffering and/or death if the obstacle was the profit-margin of a corporate entity.
The reasons why these contexts are described as 'dilemmas' is because they aren't as easy to dictate as you are trying to claim. 'Big Pharma' would have no incentive to produce life-saving medicines if they couldn't reap huge profits. Likewise you wouldn't enjoy watching a loved one suffer or die because you were born in a deprived area and couldn't afford (or access) the medicines.
daskakik
reply to post by OccamsRazor04
Please don't put words in my mouth and India isn't stealing it.
OccamsRazor04
daskakik
reply to post by OccamsRazor04
Please don't put words in my mouth and India isn't stealing it.
India admits they are stealing it. They admit there is a patent preventing any generics from being made. They are rationalizing the theft. I put no words in your mouth, it's what you said.
So since India admits they are stealing it, why is it ok for them to do so? What other countries can steal it? Can every country steal it? If not, why not? If every country did steal it, who would make any new drugs of this nature?
You have zero answers for those questions.
charles1952
reply to post by VoidHawk
Dear VoidHawk,
I'm a little surprised you mentioned Health Care. The things I've been hearing are that the NHS is draining money left and right, hospital conditions are falling, and some patients go for a day or two without being seen by anyone on the staff.
The wind farms are losing money that the taxpayer's keep propping up, meaning higher energy prices.
I'm not sure that socializing an industry lowers it's production costs by enough to make a difference, but it is now under government ownership. We have LOTS of experience of what happens when the government tries to run an industry.
With respect,
Charles1952
One year of treatment with Nexavar, used largely in liver and kidney cancer cases, costs $96,000 in the U.S. and $69,000 in India, or 41 times the per capita income; India's Natco Ltd. made it for $177 a year.
FyreByrd
ketsuko
This is probably because after spending all the millions/billions it costs to develop the drug, places like India and Australia have laws on the books that will allow them to simply strip a drug's patents and open it immediately to generic production if they deem the finished costs too expensive.
There is no protection of intellectual property at all. So why should the company take its medications to those countries again if they cannot expect any return on their investment and will have their intellectual property pirated and potentially sold out from under them everywhere across the globe by others who will make pure profits off of something they did no work to develop?
It represents a major loss on the balance sheet, a potential total loss.
But I guess if the company goes bankrupt ... then we can just expect no new drugs at all. After all, the generic producers aren't making anything except what they're taking from the big dogs who can afford to put the time and effort into R & D.
Sound business practice is to develop and produce products that can be utilitied and afforded by a wide segment of the population. This is elitist Blankity Blank sucking up more dollars that would have been better spent on safe, effective, easy to administer drugs that would benefit more then a handfull of people.(a hand full in todays population being thousands).
When Mercedes first came out with the airbag (I'm not certain of the company or the details - but this is true) they opened the patent for all car manufacturers to use (not license to use for money) because it was 'the right thing to do'.
Altruism must be rewarded. Sadism must be punished.
VoidHawk
Helping the sick should NOT be about profit!
Drug companies should all be brought under state control, that way the greedy shareholders and execs are removed from the cost of production meaning cheaper health care for EVERYONE!
VoidHawk
Drug companies should all be brought under state control, that way the greedy shareholders and execs are removed from the cost of production meaning cheaper health care for EVERYONE!
FyreByrd
I know my pro-big-business friends will rail about 'research costs' and 'regulations' but this is just sick.
OccamsRazor04
Now what if you spent hundreds of millions of dollars, and the man you gave the water to had a bad reaction and he sued you for another $50 million. Then Africa said we don't care you spent your money, we're taking your technology and not paying you a penny for it. Then the guy down the street took your technology and was selling the water at the same price you did, without paying any of the cost.
You think the next guy wanting to create something is going to waste his money doing it?
daskakik
OccamsRazor04
You think the next guy wanting to create something is going to waste his money doing it?
Wow that sounds bad but let's look at some facts:
According to the info presented the R&D for Nexavar was $275 million and Bayer recieved Orphan Drug designation which means that the US taxpayer footed up to 50% of that.
Onyx (co-developer) stated that sales for 2006 totaled $164 million and by 2012 sales were over $1 Billion.
What Natco offers:
Natco Pharma (the Indian company) offers the medication at $177 a month and claims to have a profit margin of around 25%. That is after paying Bayer a 6% royalty.
By the way, there were 700,000 cases of liver cancer diagnosed in 2006. If they had made the drug available at $200/month ($2,400/year) and half of those patients had bought it they would have made almost $50 million (in profit) after recovering their R&D costs. Every year after that would have been gravy.
Sounds a little different than your "what if".